Research suggests that Melanotan 2 functions as a non-selective melanocortin receptor agonist, with possible activity at MC1R, MC3R, MC4R, and MC5R
The 2.4mg maintenance dose provides optimal results based on clinical trials and should be reached following the prescribed titration schedule
Heart and circulatory physiology (2014) Sosne G, Ousler GW Clinical ophthalmology (Auckland, N.Z.) (2015) Ruff D, et al
Full-text screening of 48 articles was subsequently performed, and 20 articles met the inclusion criteria (Figure 1)
Wawrzeczyk A et al
En humanos ya se estn probando en el contexto de enfermedades relacionadas con la edad, como el cncer o el alzhimer, afirma Salvador Macip.